$1,187,009,300 in Total Settlement Funds Available. See if you qualify!Find Out More

Orphazyme A/S Settlement
(NASDAQ: ORPH)
Settlement

Claim Deadline: January 17, 2024

Settlement Fund: $2,500,000

Settlement Class

All persons or entities that purchased, or otherwise acquired, the American Depositary Shares (“ADS”) of Orphazyme A/S (“Orphazyme”) (NASDAQ: ORPH) in its September 2020 Initial Public Offering (“IPO”) or at any time between September 29, 2020 and November 4, 2021, both dates inclusive

Important Documents

Settlement Notice

Proof Of Claim

Settlement Status

Disbursed

Class Period

September 29, 2020 - February 02, 2022

Settlement Hearing Date

February 07, 2024

Opt-Out Deadline

January 17, 2024

Settlement Website

https://www.orphsecuritieslitigation.com/

Claims Admin

A.B. Data, Ltd.
Orphazyme Securities Litigation
Claims Administrator
c/o A.B. Data, Ltd.
P.O. Box 173018
Milwaukee, WI 53217
+1 800-918-9014
info@OrphSecuritiesLitigation.com

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.